Hypermarcas S/A ADR | Mutual Funds
Mutual Funds that own Hypermarcas S/A ADR
1,108,825
0.18%
753,400
1.13%
05/31/2018
MGI Funds Plc - Emerging Markets Equity Fund
457,400
0.07%
457,400
0.18%
12/31/2017
233,361
0.04%
0
0.6%
06/30/2018
Scotia Private Emerging Markets Pool
162,000
0.03%
162,000
0.47%
12/31/2017
80,486
0.01%
80,486
0.02%
12/31/2017
Scotia Balanced Opportunities Fund
73,100
0.01%
73,100
0.07%
12/31/2017
American Beacon Acadian Emerging Markets Mngd. Volatility Fund
46,800
0.01%
46,800
0.91%
01/31/2018
Aviva Investors - Global Emerging Markets Index Fund
45,350
0.01%
9,000
0.05%
12/31/2017
Bradesco Global Funds - Latin America (ex-Brazil) Equity
18,900
0%
18,900
1.41%
12/31/2017
2,983
0%
2,983
0.01%
12/31/2017
| Address |
Rua Nova Cidade, Nº 404
São Paulo Sao Paulo 04547
Brazil
|
|
Employees
|
- |
| Website |
http://www.hyperapharma.com.br |
| Updated |
07/08/2019 |
| Hypera SA is a pharmaceutical company which manufactures and distributes medical and cosmetics products. It offers business through Prescription Products, Consumer Health, and Similar and Generic segments. The Prescription Products segment deals with therapeutic medicines and dermocosmetics. |
